Importance Although vaccination substantially reduces the risk of severe COVID-19, it is yet
unknown whether vaccinated patients who develop COVID-19 and require invasive …

Accepted: 4 Aug. 2020 COVID-19 is a newly discovered, highly infectious disease and has
rapidly spread into at least 213 countries as a pandemic. This paper is a comprehensive …

Background Acute respiratory distress syndrome is a potentially fatal postoperative
complication. We aimed to estimate temporal trends of the representation of patients with …

Background Acute hypoxemic respiratory failure (HRF) is associated with high morbidity and
mortality, but its heterogeneity challenges the identification of effective therapies. Defining …

Background Before the pandemic of coronavirus disease (COVID-19), rapidly improving
acute respiratory distress syndrome (ARDS), mostly defined by early extubation, had been …

OBJECTIVES: Improving the efficiency of clinical trials in acute hypoxemic respiratory failure
(HRF) depends on enrichment strategies that minimize enrollment of patients who quickly …

Background Rapidly improving acute respiratory distress syndrome (RIARDS) is an
increasingly appreciated subgroup of ARDS in which hypoxemia improves within 24 h after …

Dear Editor, Outcomes of critically ill patients with neutropenia (including those with acute
respiratory distress syndrome (ARDS)) improve over time, as suggested by data from …

Purpose Trajectory of acute respiratory distress syndrome (ARDS) spans from rapidly
improving cases to cases receiving prolonged mechanical ventilation (PMV). We attempted …

Clinical trials targeting patients who receive mechanical ventilation often fail (1). There are
numerous causes of this failure, from unmodifiable patient characteristics resulting in poor …